Xenon Pharmaceuticals Inc (XENE)
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
Aptar - Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
Aveanna to Participate at the BofA Securities Home Care Conference
BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Medtronic announces cash dividend for third quarter of fiscal year 2026
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel